Mechanisms of action of CTLA-4 and CTLA-4 inhibitors (ipilimumab) A)... | Download Scientific Diagram
Combined anti‐PD‐1 and anti‐CTLA‐4 checkpoint blockade: Treatment of melanoma and immune mechanisms of action - Willsmore - 2021 - European Journal of Immunology - Wiley Online Library
Synergistic Effect of CTLA-4 Blockade and Cancer Chemotherapy in the Induction of Anti-Tumor Immunity | PLOS ONE
Clinical experience with CTLA-4 blockade for cancer immunotherapy: From the monospecific monoclonal antibody ipilimumab to probodies and bispecific molecules targeting the tumor microenvironment - ScienceDirect
Anti-CTLA-4 therapy for malignant mesothelioma | Immunotherapy
CTLA-4 blockade drives loss of Treg stability in glycolysis-low tumours | Nature
Cancers | Free Full-Text | CTLA-4 in Regulatory T Cells for Cancer Immunotherapy
Schematic representation of CTLA-4 and anti-CTLA-4 mechanisms of action... | Download Scientific Diagram
Inhibitors of immune checkpoints—PD-1, PD-L1, CTLA-4—new opportunities for cancer patients and a new challenge for internists and general practitioners | SpringerLink
Potential function of CTLA‑4 in the tumourigenic capacity of melanoma stem cells
Combined anti‐PD‐1 and anti‐CTLA‐4 checkpoint blockade: Treatment of melanoma and immune mechanisms of action - Willsmore - 2021 - European Journal of Immunology - Wiley Online Library
Mechanism of action of anti-PD-1, anti-PD-L1, and anti-CTLA4.... | Download Scientific Diagram
John Libbey Eurotext - Journal de Pharmacie Clinique - PK/PD relationships of therapeutic monoclonal antibodies used in oncology
800 Dual targeting of CTLA-4 and CD47 on Treg cells rejuvenates immunity against solid tumors | Journal for ImmunoTherapy of Cancer
Molecules | Free Full-Text | Molecular Interactions of Antibody Drugs Targeting PD-1, PD-L1, and CTLA-4 in Immuno-Oncology | HTML
Combined immune checkpoint blockade (anti-PD-1/anti-CTLA-4): Evaluation and management of adverse drug reactions - ScienceDirect
Immunothérapie dans les cancers digestifs – FMC-HGE
800 Dual targeting of CTLA-4 and CD47 on Treg cells rejuvenates immunity against solid tumors | Journal for ImmunoTherapy of Cancer
Response to anti-CTLA-4 immunotherapy Day 16 post-YUMMER1.7... | Download Scientific Diagram
A reappraisal of CTLA-4 checkpoint blockade in cancer immunotherapy | Cell Research
Frontiers | Beyond T-Cells: Functional Characterization of CTLA-4 Expression in Immune and Non-Immune Cell Types
Frontiers | Anti-PD-1 and Anti-CTLA-4 Therapies in Cancer: Mechanisms of Action, Efficacy, and Limitations
Anti-CTLA-4 antibodies in cancer immunotherapy: selective depletion of intratumoral regulatory T cells or checkpoint blockade? | Cell & Bioscience | Full Text
